Fernanda S. Melo-Correia
Salvador, BA, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study.
Journal: Journal of psychiatric research
Published: February 07, 2023
Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.
Journal: Journal of affective disorders
Published: January 11, 2023
Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.
Journal: Trends in psychiatry and psychotherapy
Published: November 17, 2022
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression.
Journal: Journal of clinical psychopharmacology
Published: June 21, 2022
Suicide attempt, impulsivity, and exposure to trauma in college students.
Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
Published: August 10, 2021
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Journal: Human psychopharmacology
Published: July 16, 2021
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
Journal: Trends in psychiatry and psychotherapy
Published: April 26, 2021
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial.
Journal: Journal of psychiatric research
Published: December 29, 2020
Letter to the editor - Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
Journal: Journal of affective disorders
Published: December 16, 2020
Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial.
Journal: General hospital psychiatry
Published: October 06, 2020
Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study.
Journal: Psychiatry research
Published: July 29, 2020
Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Journal: European archives of psychiatry and clinical neuroscience
Published: December 23, 2019
Last Updated: 09/26/2026